Abstract

In this chapter, we focus on the 60 KDa Heat Shock Protein (Hsp60) and discuss some of its biological, molecular and pathological features. The structural and mechanistic aspect of the Hsp60 folding cycle will be also presented. We further illustrate how Hsp60 may be involved in many diseases and therefore considered as an effective therapeutic or theranostic target. Finally, the state-of-the-art on the development of Hsp60 and bacterial GroEL inhibitors and modulators of their expression will be illustrated. This is discussed in the light of a negative chaperonotherapy, and the consequent development of inhibitors, as well as positive chaperonotherapy, in the event its excessive activity is a disease-contrasting event.
Lingua originaleEnglish
Titolo della pubblicazione ospiteHeat Shock Protein 60 in Human diseases and disorders
Pagine27-39
Numero di pagine13
Stato di pubblicazionePublished - 2019

Serie di pubblicazioni

NomeHEAT SHOCK PROTEINS

Fingerprint

Chaperonin 60
Therapeutics
Theranostic Nanomedicine

Cita questo

Buscemi, S., Palumbo Piccionello, A., Marzullo, P., & Pace, A. (2019). Hsp60 Inhibitors and Modulators. In Heat Shock Protein 60 in Human diseases and disorders (pagg. 27-39). (HEAT SHOCK PROTEINS).

Hsp60 Inhibitors and Modulators. / Buscemi, Silvestre; Palumbo Piccionello, Antonio; Marzullo, Paola; Pace, Andrea.

Heat Shock Protein 60 in Human diseases and disorders. 2019. pag. 27-39 (HEAT SHOCK PROTEINS).

Risultato della ricerca: Chapter

Buscemi, S, Palumbo Piccionello, A, Marzullo, P & Pace, A 2019, Hsp60 Inhibitors and Modulators. in Heat Shock Protein 60 in Human diseases and disorders. HEAT SHOCK PROTEINS, pagg. 27-39.
Buscemi S, Palumbo Piccionello A, Marzullo P, Pace A. Hsp60 Inhibitors and Modulators. In Heat Shock Protein 60 in Human diseases and disorders. 2019. pag. 27-39. (HEAT SHOCK PROTEINS).
Buscemi, Silvestre ; Palumbo Piccionello, Antonio ; Marzullo, Paola ; Pace, Andrea. / Hsp60 Inhibitors and Modulators. Heat Shock Protein 60 in Human diseases and disorders. 2019. pagg. 27-39 (HEAT SHOCK PROTEINS).
@inbook{97629db4e18c4ad69951a1a0e68eca8e,
title = "Hsp60 Inhibitors and Modulators",
abstract = "In this chapter, we focus on the 60 KDa Heat Shock Protein (Hsp60) and discuss some of its biological, molecular and pathological features. The structural and mechanistic aspect of the Hsp60 folding cycle will be also presented. We further illustrate how Hsp60 may be involved in many diseases and therefore considered as an effective therapeutic or theranostic target. Finally, the state-of-the-art on the development of Hsp60 and bacterial GroEL inhibitors and modulators of their expression will be illustrated. This is discussed in the light of a negative chaperonotherapy, and the consequent development of inhibitors, as well as positive chaperonotherapy, in the event its excessive activity is a disease-contrasting event.",
author = "Silvestre Buscemi and {Palumbo Piccionello}, Antonio and Paola Marzullo and Andrea Pace",
year = "2019",
language = "English",
isbn = "978-3-030-23153-8; 978-3-030-23154-5",
series = "HEAT SHOCK PROTEINS",
pages = "27--39",
booktitle = "Heat Shock Protein 60 in Human diseases and disorders",

}

TY - CHAP

T1 - Hsp60 Inhibitors and Modulators

AU - Buscemi, Silvestre

AU - Palumbo Piccionello, Antonio

AU - Marzullo, Paola

AU - Pace, Andrea

PY - 2019

Y1 - 2019

N2 - In this chapter, we focus on the 60 KDa Heat Shock Protein (Hsp60) and discuss some of its biological, molecular and pathological features. The structural and mechanistic aspect of the Hsp60 folding cycle will be also presented. We further illustrate how Hsp60 may be involved in many diseases and therefore considered as an effective therapeutic or theranostic target. Finally, the state-of-the-art on the development of Hsp60 and bacterial GroEL inhibitors and modulators of their expression will be illustrated. This is discussed in the light of a negative chaperonotherapy, and the consequent development of inhibitors, as well as positive chaperonotherapy, in the event its excessive activity is a disease-contrasting event.

AB - In this chapter, we focus on the 60 KDa Heat Shock Protein (Hsp60) and discuss some of its biological, molecular and pathological features. The structural and mechanistic aspect of the Hsp60 folding cycle will be also presented. We further illustrate how Hsp60 may be involved in many diseases and therefore considered as an effective therapeutic or theranostic target. Finally, the state-of-the-art on the development of Hsp60 and bacterial GroEL inhibitors and modulators of their expression will be illustrated. This is discussed in the light of a negative chaperonotherapy, and the consequent development of inhibitors, as well as positive chaperonotherapy, in the event its excessive activity is a disease-contrasting event.

UR - http://hdl.handle.net/10447/389552

M3 - Chapter

SN - 978-3-030-23153-8; 978-3-030-23154-5

T3 - HEAT SHOCK PROTEINS

SP - 27

EP - 39

BT - Heat Shock Protein 60 in Human diseases and disorders

ER -